Evidence map›Paper›PMID 30963815›Full record

ArticleStatistical methods in medical research2020

Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer data.

Sandrine Boulet, Moreno Ursino, Peter Thall, Bruno Landi, Céline Lepère, Simon Pernot, Anita Burgun, Julien Taieb, Aziz Zaanan, Sarah Zohar and 1 more

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sandrine BouletINSERM U1138, University Paris Descartes, Sorbonne University, Paris, France.ORCID 0000-0001-9863-5466
Moreno UrsinoINSERM U1138, University Paris Descartes, Sorbonne University, Paris, France.ORCID 0000-0002-5709-4322
Peter ThallDepartment of Biostatistics, M.D. Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-7293-529X
Bruno LandiDepartment of Digestive Oncology, Hôpital européen Georges-Pompidou, AP-HP, Paris, France.
Céline LepèreDepartment of Digestive Oncology, Hôpital européen Georges-Pompidou, AP-HP, Paris, France.
Simon PernotDepartment of Digestive Oncology, Hôpital européen Georges-Pompidou, AP-HP, Paris, France.
Anita BurgunINSERM U1138, University Paris Descartes, Sorbonne University, Paris, France.
Julien TaiebDepartment of Digestive Oncology, Hôpital européen Georges-Pompidou, AP-HP, Paris, France.
Aziz ZaananDepartment of Digestive Oncology, Hôpital européen Georges-Pompidou, AP-HP, Paris, France.
Sarah ZoharINSERM U1138, University Paris Descartes, Sorbonne University, Paris, France.
Anne-Sophie JannotINSERM U1138, University Paris Descartes, Sorbonne University, Paris, France.

Funding

THE THERAPY OF AMLP01CA055164 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI THOMAS, MATTIE J · 1992 to 2011
$25.3M
NCI NIH HHS P01 CA055164
6 · The paper itself

Abstract

backgroundBuilding tools to support personalized medicine needs to model medical decision-making. For this purpose, both expert and real world data provide a rich source of information. Currently, machine learning techniques are developing to select relevant variables for decision-making. Rather than using data-driven analysis alone, eliciting prior information from physicians related to their medical decision-making processes can be useful in variable selection. Our framework is electronic health records data on repeated dose adjustment of Irinotecan for the treatment of metastatic colorectal cancer. We propose a method that incorporates elicited expert weights associated with variables involved in dose reduction decisions into the Stochastic Search Variable Selection (SSVS), a Bayesian variable selection method, by using a power prior.

methodsClinician experts were first asked to provide numerical clinical relevance weights to express their beliefs about the importance of each variable in their medical decision making. Then, we modeled the link between repeated dose reduction, patient characteristics, and toxicities by assuming a logistic mixed-effects model. Simulated data were generated based on the elicited weights and combined with the observed dose reduction data via a power prior. We compared the Bayesian power prior-based SSVS performance to the usual SSVS in our case study, including a sensitivity analysis using the power prior parameter.

resultsThe selected variables differ when using only expert knowledge, only the usual SSVS, or combining both. Our method enables one to select rare variables that may be missed using only the observed data and to discard variables that appear to be relevant based on the data but not relevant from the expert perspective.

conclusionWe introduce an innovative Bayesian variable selection method that adaptively combines elicited expert information and real world data. The method selects a set of variables relevant to model medical decision process.

Indexed as

AgedAged, 80 and overBayes TheoremClinical Decision-MakingColonic NeoplasmsDose-Response Relationship, DrugElectronic Health RecordsExpert TestimonyFemaleHumansIrinotecanLogistic ModelsMaleNeoplasm MetastasisPrecision MedicineResearch DesignIrinotecanTopoisomerase I InhibitorsBayesian variable selectionclinical relevance weights elicitationelectronic health recordpower prior methodrepeated measures

Identifiers

PMID30963815
PMCPMC9133490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.